AIDS Research and Treatment / 2015 / Article / Fig 1

Research Article

Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial

Figure 1

(a) HIV-1 RNA suppression on DRV/r-based second-line treatment, by dose. Patients with HIV-1 subtype B virus. (b) HIV-1 RNA suppression on DRV/r-based second-line treatment, by dose. Patients with HIV-1 subtype non-B virus.
(a)
(b)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.